Founded in 1999 in Copenhagen, Denmark, we are a dual-listed, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer. We are led by an experienced international management team. Our proprietary product pipeline and next-generation antibody technologies are the result of our strong company culture and a deep passion for innovation. We are inspired by nature and the power of the immune system to transform cancer treatment.
Find locations served, office locations
- Business Type:
- Industry Type:
- Clinical Services
- Market Focus:
- Internationally (various countries)
- Year Founded:
- Over 1000
Genmab is focused on the creation and development of innovative and differentiated antibody products, with the aim of improving the lives of cancer patients. Watch this video to learn more about our core values, products, and track record.
Combating cancer through the power of human antibodies
Our core purpose is to improve the lives of patients with cancer by creating and developing innovative and differentiated antibody products. It is our reason for being.
Our core values
In our quest to turn science into medicine, we use these guideposts to transform the future of cancer treatment:
- Passion for innovation
- Determination—being the best at what we do
- Integrity—we do the right thing
- We work as one team and respect each other
Our key accomplishments
Each of our achievements stands as evidence of our unyielding determination, including:
- Creators of multiple marketed products*
- Inventors of four proprietary technologies
- Growing multiple proprietary clinical programs
- Pioneers of a robust pre-clinical pipeline
- World-class leaders with antibody and R&D expertise
- Partners of choice with strategic collaborations
- Solid financials
- Building and expanding our capabilities with more than 1,200 employees across our four international locations
Corporate Social Responsibility
Since Genmab’s founding in 1999, our work has been anchored in our core purpose to improve the lives of patients by creating and developing innovative antibody medicines.
With our core values of innovation, determination, integrity and teamwork and inspiring 2025 vision to transform the cancer treatment guiding our work, being sustainable and socially responsible is fundamental to the way we work at Genmab.
Social Responsibility & Sustainability
Genmab’s comprehensive approach to corporate social responsibility (CSR) is grounded in our commitment to sustainability, driven by our purpose and vision, and guided by our core values. We have implemented new CSR-related policies, procedures and programs to ensure that the value we provide to our stakeholders is long-lasting. Read more about how we are integrating CSR into our operations.
We are committed to ensure our actions benefit our stakeholders – patients, caregivers, healthcare professionals, employees, our partners, shareholders – and society as a whole. Being socially responsible is fundamental to the way we work at Genmab.
Our commitment to CSR is anchored in our company’s core purpose to improve the lives of patients by creating and developing innovative antibody products and our vision that by 2025 our own product has transformed cancer treatment and we have a pipeline of knock-your-socks-off antibodies. Our vision inspires and motivates us. Our teams are focused on developing innovative therapies that will transform how people fight cancer, changing it from a disease to be afraid of to a condition that patients may live with — and overcome.